510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K933188Substantially Equivalent

Dade (Pai-1) Chromogenic Assay Dade Coagtrol-Pai

Baxter Diagnostics, Inc., Miami FL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K933188 is the FDA 510(k) clearance record for DADE (PAI-1) CHROMOGENIC ASSAY DADE COAGTROL-PAI, a class II device, cleared for Baxter Diagnostics, Inc. on under FDA product code JPA (System, Multipurpose For In Vitro Coagulation Studies). FDA records list 72 510(k) clearances for Baxter Diagnostics, Inc., from to . As of , FDA records show no recalls naming K933188.

Clearance record

Decision date
Received
(84 days to decision)
Product code
JPA System, Multipurpose For In Vitro Coagulation Studies
Regulation
21 CFR 864.5425
Device class
Class II
Review panel
Hematology
Applicant
Baxter Diagnostics, Inc. P.O.Box 520672, Miami FL
510(k) summary
Summary
Third party review
No

Clearances, product code JPA

Trailing 12 months
1 clearance under product code JPA in the twelve months to October 2026, April 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code JPA, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20261
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260